SWYX Pharma

Swixx BioPharma is a leading commercial-stage biopharmaceutical company that provides a comprehensive market access and commercialization platform for multinational pharmaceutical and biotech companies in Central and Eastern Europe (CEE), Greece, and Russia. Headquartered in Baar, Switzerland, the company operates as a strategic partner for global innovators, managing the entire lifecycle of specialty medicines from regulatory registration and pricing to medical affairs and sales. Swixx represents a diverse portfolio of high-value products across therapeutic areas such as oncology, hematology, rare diseases, and neurology, partnering with industry leaders like Bristol Myers Squibb and Gilead Sciences. By leveraging its extensive regional infrastructure and local expertise, Swixx enables its partners to reach patients in complex emerging markets without the need for a direct local presence. The company has grown rapidly through both organic expansion and strategic acquisitions of regional business units from major pharmaceutical firms.